Real World Evidence on Second-Line Palliative Chemotherapy in Advanced Pancreatic Cancer

Real World Evidence on Second-Line Palliative Chemotherapy in Advanced Pancreatic Cancer

Background: The outcome and tolerability of palliative second line chemotherapy for advanced pancreatic cancer (APC) in real life patients are largely unknown. Prognostic parameters for risk stratification and treatment guidance are lacking.Materials and Methods: A population based multicenter retro...

Full description

Bibliographic Details
Main Authors: Emma Gränsmark, Nellie Bågenholm Bylin, Hakon Blomstrand, Mats Fredrikson, Elisabeth Åvall-Lundqvist, Nils O. Elander
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-07-01
Series:Frontiers in Oncology
Subjects:
pancreatic cancer
palliative therapy
cancer chemotherapy
prognostic factors
CA-19-9 antigen
human plasma albumin
Online Access:https://www.frontiersin.org/article/10.3389/fonc.2020.01176/full

Internet

https://www.frontiersin.org/article/10.3389/fonc.2020.01176/full

Similar Items